Image

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

Recruiting
18 years of age
Male
Phase N/A

Powered by AI

Overview

The study is aimed to provide high-risk, HIV-infection, men who have sex with men (MSM) with healthcare education regarding viral hepatitis C, through either serious game intervention or traditional online health education. After the education, each participants will be followed for 48 weeks and the change of risky sexual behaviors, acquisition of HCV and other STIs will be followed during the study periods.

Description

High-risk MSM living with HIV were participated in our study will be assigned (by randomization) to either:

  1. Serious game intervention: 1 single session of serious game for the participants to play (estimation to take 25-40 minutes). Hepatitis C virus (HCV)-related healthcare informations, including the severity of illness, route of transmission, preventive strategies and treatment options, would be embedded in the game.
  2. Traditional online health education (reading materials): 1 single session of healthcare education regarding HCV (with similar contents) will be provided.

After the healthcare intervention, each participants will be followed for 48 weeks. Assessment of risky sexual practice (by questionnaire), test of plasma HCV RNA and serological test of syphilis (optional), and detection of sexually-transmitted bacterial pathogens (optional) will be performed at the enrollment and then every 12 weeks during the observation.

Eligibility

Inclusion Criteria:

  • High-risk MSM living with HIV, defined as:
    1. Had prior HCV infection, and had cleared HCV through treatment or spontaneously
    2. Had any STI within the past 12 months
    3. Had any unexplained elevation of liver transaminase in the past 6 months
    4. Had at least 1 unprotected anal sex during the past 6 months
  • Being able to use mobile smartphone and understand study materials
  • Repeat entry of study is permitted, but the interval between health education intervention should >52 weeks.

Exclusion Criteria:

  • HCV RNA positive and yet clear virus (nor reaching SVR12).
  • Admission for any acute illness (including AIDS-defining conditions)

Study details

Viral Hepatitis C

NCT05751889

National Taiwan University Hospital

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.